21.06.2012 • News

Cabot to Buy Dutch Company Norit for $1.1 Billion

Chemicals maker Cabot said it will buy activated carbon manufacturer Norit for $1.1 billion as it moves its focus to higher-margin specialty chemicals.

Cabot will buy Netherlands-based Norit from affiliates of British private equity fund Doughty Hanson & Co Managers and Dutch investment firm Euroland Investments. Norit was acquired by a group of investors led by Doughty Hanson in 2007.

"This acquisition supports the ongoing transformation of our portfolio to a higher margin, less cyclical, specialty chemicals focused company," Cabot Chief Executive Patrick Prevost said.

Reuters reported in April that Norit, which had earlier announced plans for a U.S. initial public offering, was also exploring a sale of itself.

Activated carbon is generally derived from charcoal and used in purification and filtration processes. Norit sold its Clean Process Technologies unit to Pentair for €503 million last year.

Cabot expects the Norit deal to add 20 to 25 cents per share to its earnings, excluding one-time costs, in 2013.

Norit operates 10 plants throughout the Americas and Europe. It had sales of $360 million in 2 011.

J.P. Morgan was Cabot's financial adviser for the deal.

 

 

 

 

 

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.